- Home
- ATYR vs HIVE Comparison
ATYR vs HIVE Comparison
Compare ATYR & HIVE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATYR
- HIVE
- Stock Information
- Founded
- ATYR 2005
- HIVE 1987
- Country
- ATYR United States
- HIVE United States
- Employees
- ATYR N/A
- HIVE N/A
- Industry
- ATYR Biotechnology: Biological Products (No Diagnostic Substances)
- HIVE
- Sector
- ATYR Health Care
- HIVE
- Exchange
- ATYR Nasdaq
- HIVE Nasdaq
- Market Cap
- ATYR 451.3M
- HIVE 459.0M
- IPO Year
- ATYR 2015
- HIVE N/A
- Fundamental
- Price
- ATYR $5.35
- HIVE $2.52
- Analyst Decision
- ATYR Strong Buy
- HIVE Strong Buy
- Analyst Count
- ATYR 5
- HIVE 6
- Target Price
- ATYR $23.25
- HIVE $6.83
- AVG Volume (30 Days)
- ATYR 5.0M
- HIVE 17.4M
- Earning Date
- ATYR 08-07-2025
- HIVE 08-14-2025
- Dividend Yield
- ATYR N/A
- HIVE N/A
- EPS Growth
- ATYR N/A
- HIVE 42.43
- EPS
- ATYR N/A
- HIVE 0.34
- Revenue
- ATYR N/A
- HIVE $128,649,000.00
- Revenue This Year
- ATYR $478.72
- HIVE $164.89
- Revenue Next Year
- ATYR $1,899.26
- HIVE $60.62
- P/E Ratio
- ATYR N/A
- HIVE $7.33
- Revenue Growth
- ATYR N/A
- HIVE 4.47
- 52 Week Low
- ATYR $1.67
- HIVE $1.26
- 52 Week High
- ATYR $7.29
- HIVE $5.54
- Technical
- Relative Strength Index (RSI)
- ATYR 52.99
- HIVE 67.34
- Support Level
- ATYR $4.58
- HIVE $2.23
- Resistance Level
- ATYR $5.03
- HIVE $2.46
- Average True Range (ATR)
- ATYR 0.34
- HIVE 0.12
- MACD
- ATYR -0.01
- HIVE 0.03
- Stochastic Oscillator
- ATYR 66.09
- HIVE 98.15
About ATYR aTyr Pharma Inc. Common Stock
aTyr Pharma Inc is a biotherapeutics company engaged in the discovery and development of first-in-class medicines from its proprietary tRNA synthetase platform. The company has concentrated its research and development efforts on a newly discovered area of biology, the extracellular functionality and signaling pathways of tRNA synthetases. Its primary focus is efzofitimod, a clinical-stage product candidate which targets NRP2 to resolve chronic inflammation that can cause to fibrosis. Efzofitimod has a novel mechanism of action for potentially treating lung inflammation and fibrosis.
About HIVE HIVE Digital Technologies Ltd.
HIVE Digital Technologies Ltd is in the business of providing infrastructure solutions in the blockchain industry. It focuses on the mining and sale of digital currencies. Its geographical segments include Canada, Sweden, Iceland, Switzerland, and Bermuda, out of which the majority of the revenue comes from Bermuda.